Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Operating Margin: 2009-2025

Historic Operating Margin for Aytu Biopharma (AYTU) over the last 17 years, with Sep 2025 value amounting to -10.83%.

  • Aytu Biopharma's Operating Margin fell 522.00% to -10.83% in Q3 2025 from the same period last year, while for Sep 2025 it was -13.19%, marking a year-over-year decrease of 968.00%. This contributed to the annual value of -11.79% for FY2025, which is 845.00% down from last year.
  • As of Q3 2025, Aytu Biopharma's Operating Margin stood at -10.83%, which was up 78.50% from -50.37% recorded in Q2 2025.
  • In the past 5 years, Aytu Biopharma's Operating Margin ranged from a high of 16.78% in Q4 2023 and a low of -220.76% during Q1 2022.
  • Its 3-year average for Operating Margin is -10.94%, with a median of -10.45% in 2024.
  • Per our database at Business Quant, Aytu Biopharma's Operating Margin plummeted by 13,159bps in 2021 and then surged by 18,311bps in 2023.
  • Quarterly analysis of 5 years shows Aytu Biopharma's Operating Margin stood at -48.84% in 2021, then spiked by 2,270bps to -26.13% in 2022, then soared by 4,292bps to 16.78% in 2023, then tumbled by 2,723bps to -10.45% in 2024, then slumped by 522bps to -10.83% in 2025.
  • Its Operating Margin was -10.83% in Q3 2025, compared to -50.37% in Q2 2025 and 13.12% in Q1 2025.